Time: 11am-12pm CET / 10am-11am GMT

Duration: 60 mins

Speakers:

• Andrea Zobel, PhD, Senior Director, Personalized Supply Chain, World Courier
• Tom Roberts, Business Development Manager UK, World Courier
• Graham Wylie, Chief Executive Officer, Medical Research Network
  
  

Overview:

The impact of the COVID-19 pandemic has propelled a historic and transformational shift in the clinical research industry, transforming clinical trials. This has meant finding alternative ways of working, such as utilizing new routes and adjusting study protocols, including a rise in demand for direct-to-patient delivery.

In this webinar we take a look at the premise of this model, how investigational medicinal products (IMP) or drugs are administered in the patient’s home, and the challenges and risks involved. 

Register now to attend the live event, learn from World Courier and Medical Research Network industry experts and discover how Direct-to-Patient services continue to experience significant growth. The session will be followed by a live Q&A with the speakers and all attendees will receive a copy of the recording to listen on-demand.

Key learnings

• Are deliveries of clinical supplies to patients allowed, forbidden or just have exceptional approval during the pandemic?
• What is the role of a homecare nurse in a decentralized clinical trial? 
• The differences between a homecare nurse and a study nurse
• How can we assure the investigator oversight in a decentralized clinical trial? 
• What is the relationship between the investigator and a homecare nurse?